Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference37 articles.
1. Both cladribine and alemtuzumab may effect MS via B-cell depletion;Baker;Neurol.(R) Neuroimmunol. Neuroinflammation,2017
2. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: rapid incidence increase among young Danish women;Birch-Johansen;Int. J. Cancer,2010
3. DNA strand breaks, NAD metabolism, and programmed cell death;Carson;Exp. Cell Res.,1986
4. Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells;Ceronie;J. Neurol.,2018
5. MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study;Comi;J. Neurol.,2013
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An update on managing patients with multiple sclerosis in primary care;JAAPA;2024-02
2. The Development of the Combination Drug Leukovir® Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review;Current Drug Targets;2023-12
3. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-11-30
4. The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis;Current Medical Research and Opinion;2023-09-19
5. Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs;Multiple Sclerosis and Related Disorders;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3